Overall CVRX gets a fundamental rating of 2 out of 10. We evaluated CVRX against 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of CVRX have multiple concerns. While showing a medium growth rate, CVRX is valued expensive at the moment.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -46.73% | ||
| ROE | -108.26% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 84.49% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.13 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.62 | ||
| Quick Ratio | 8.6 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
8.45
+0.03 (+0.36%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 3.96 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 4.61 | ||
| P/tB | 4.61 | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -46.73% | ||
| ROE | -108.26% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 84.49% | ||
| FCFM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.03 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 75.3% | ||
| Cap/Sales | 1.01% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 9.62 | ||
| Quick Ratio | 8.6 | ||
| Altman-Z | -5.13 |
ChartMill assigns a fundamental rating of 2 / 10 to CVRX.
ChartMill assigns a valuation rating of 0 / 10 to CVRX INC (CVRX). This can be considered as Overvalued.
CVRX INC (CVRX) has a profitability rating of 1 / 10.
The Earnings per Share (EPS) of CVRX INC (CVRX) is expected to grow by 22.97% in the next year.